Mirum Pharmaceuticals, Inc. reported total revenue of $185.7 million for the quarter ended September 30, 2026, compared to $133.0 million for the quarter ended September 30, 2025. Total operating expenses were $245.5 million for the quarter ended September 30, 2026 compared to $1
Mirum Pharmaceuticals Reports Q3 2026 Financial Results and Raises Full-Year Sales Guidance
Mirum Pharmaceuticals, Inc. reported total revenue of $185.7 million for the quarter ended September 30, 2026, compared ...
By Dhallo News · November 4, 2026 at 5:12 AM IST
Have feedback on this article?Report error or suggestion
